1,038 results found

Madras High Court has ordered the government to ensure that no prescription medicine is sold online without a license

On November 31, 2011, the Ministry of Health and Family Welfare had proposed certain draft amendments to the Drugs and Cosmetic Rules, 1945 to ensure payment of compensation to the study subject for clinical trial related injury or death.

The Covid-19 crisis has brought up several challenges. With India under lockdown, one such challenge is ensuring people can consult doctors and access medicines with ease.

The nod of the Union Cabinet for the new pricing policy is a boon to the Indian pharmaceutical Industry.

On February 20, 2018, the US FDA finalized a rule that requires medical device clinical investigations conducted outside the US to flexibly conform with good clinical practice standards.

Earlier in the month of November, Indian generic drug maker Cipla Ltd. had requested the Central government to revoke five patents held by Swiss firm Novartis AG on respiratory drug Indacetorol, used for the treatment of Chronic Obstructive Pulmonary Disease (COPD) under the brand name ‘ONBREZ’.

The plaintiff is a multinational company involved in the production and manufacture of pharmaceutical drugs and had acquired patent rights for its products under Indian Patent Nos. 243301 and 227719.

A patent titled "Pharmaceutical Composition Comprising Phenyl Piperazine Derivatives as Serotonin Reuptake Inhibitors" (Patent number -IN227963) was granted to H LUNDBECK A/S & ANR on 27 December 2009

A patent is a right granted to the owner to stop others from using his invention without his consent for making, using, selling or offering for sale his patent.

It's sometimes better to think about the things that cannot be patented to get a sense of the contours of patentability. Article 27.1 of the TRIPS Agreement states that patents must be available...

The granting of secondary use patents in the pharmaceutical industry has become more prominent after the negotiations of the TRIPS Agreement in 1995.

It is not new that the Supreme Court had cautiously laid down the seven principles for determining confusion or deceptiveness in pharmaceutical products.

Even though the virus is yet to spread in parts of India, it is imperative for the hoi polloi to be aware of its spread, chiefly for two reasons.

The Supreme Court of India ("Supreme Court"), in the case of Sun Pharmaceutical Industries Ltd. vs. Union of India and Others, has upheld the recovery demand issued by the National Pharmaceutical Pricing Authority...

On March 23, 2018, the Ministry of Health and Family Welfare, Government of India, has, in public interest, prohibited the use of ADRDT for routine diagnosis of malaria with immediate effect.

On January 03, 2018, Novartis announced that KisqaliR (Ribociclib) has received FDA Breakthrough Therapy designation for initial endocrine-based treatment, in combination with tamoxifen or an aromatase inhibitor,...

Arrests made for role in the 2023 leak of COVID-19 data held by Indian Council of Medical Research (ICMR): In October 2023, the ICMR COVID-19 testing database was hacked...

The Central Government, exercising its rule-making authority under Section 12(1) and Section 33(1) of the Drugs and Cosmetics Act, 1940, has proposed significant amendments to the Medical Devices Rules, 2017...